InterviewSolution
Saved Bookmarks
| 1. |
Injecting functional adenosine deaminase into a patients (lacking ADA gene) blood cells may be considered asA. Gene therapyB. Enzyme replacement therapyC. Both (1) & (2)D. Genetic engineering |
| Answer» Correct Answer - B | |